{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:35:58Z","timestamp":1753889758167,"version":"3.41.2"},"reference-count":118,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Prisoners represent high-risk behaviors such as injecting drug use, sharing\nsyringes, tattooing, and unprotected sexual intercourse. The authors aimed to study the prevalence of\nhepatitis B, hepatitis C, and hepatitis D in the prisoners.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We conducted a systematic search using the keywords in online databases of PubMed, Web\nof Science, Scopus, and Science Direct. Two independent researchers examined the quality of the articles\nand the probable risk of bias. The most relevant articles by title and abstract were retrieved. Finally,\nthe full text of selected articles was read, and the critical findings were extracted.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Reviews of 23 studies showed that most prisoners are susceptible to hepatitis B and hepatitis\nC. One study also indicated that prisoners could be infected with hepatitis A and hepatitis E. The most\ncommon routes of hepatitis transmission in prisons were intravenous drug use, needle sharing, tattooing,\nand unsafe sex with multiple sexual partners.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>High-risk sexual behaviors, shared contaminated needles for IV drug injection, and tattooing\nare the principal routes of hepatitis transmission among prison inmates. Hepatitis treatment is\nfeasible and could be useful for infected prisoners undergoing a well-designed treatment program.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526522666220620115006","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T06:44:23Z","timestamp":1655793863000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Hepatitis in Prisoners: A Systematic Review of Current\nEvidence"],"prefix":"10.2174","volume":"22","author":[{"given":"Salar","family":"Pashangzadeh","sequence":"first","affiliation":[{"name":"Iranian Research Center for HIV\/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of\nMedical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SeyedAhmad","family":"SeyedAlinaghi","sequence":"additional","affiliation":[{"name":"Iranian Research Center for HIV\/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of\nMedical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Dadras","sequence":"additional","affiliation":[{"name":"Section Global Health and Rehabilitation, Western Norway University and Applied\nSciences, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Pashaei","sequence":"additional","affiliation":[{"name":"Iranian Research Center for HIV\/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of\nMedical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Soleymanzadeh","sequence":"additional","affiliation":[{"name":"School of Medicine, Ophthalmology Resident at Farabi Hospital, Tehran University of\nMedical Sciences (TUMS), Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Barzegary","sequence":"additional","affiliation":[{"name":"School of Medicine, Islamic Azad University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pegah","family":"Mirzapour","sequence":"additional","affiliation":[{"name":"Iranian Research Center for HIV\/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of\nMedical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Vahedi","sequence":"additional","affiliation":[{"name":"School of Medicine,\nTehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirata","family":"Fakhfouri","sequence":"additional","affiliation":[{"name":"School of Medicine, Islamic Azad University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayebeh","family":"Noori","sequence":"additional","affiliation":[{"name":"Department of Health Information Technology, Zabol\nUniversity of Medical Sciences, Zabol, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Hossein Irani","sequence":"additional","affiliation":[{"name":"Department of Health Information Technology, Khalkhal University of\nMedical Sciences, Khalkhal, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-2973","authenticated-orcid":true,"given":"Esmaeil","family":"Mehraeen","sequence":"additional","affiliation":[{"name":"Department of Health Information Technology, Khalkhal University of\nMedical Sciences, Khalkhal, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayesteh","family":"Jahanfar","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Tufts University School of\nMedicine, Massachusetts, Boston, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1108296","volume":"366","author":"Fauci A.S.","year":"2012","unstructured":"Fauci A.S.; Morens D.M.; The perpetual challenge of infectious diseases. N Engl J Med 2012,366(5),454-461","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.47176\/mjiri.34.109","volume":"34","author":"Ale-Ebrahim J.","year":"2020","unstructured":"Ale-Ebrahim J.; Janani L.; Seyed A.S.A.; Patterns of high-risk behaviors associated with HIV among male prisoners: A latent class analysis. Med J Islam Repub Iran 2020,34,109","journal-title":"Med J Islam Repub Iran"},{"year":"2017","key":"ref=3","unstructured":"Global hepatitis reportAvailable from: 2017"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/1570162X18666200605152317","volume":"18","author":"Najafi Z.","year":"2020","unstructured":"Najafi Z.; Taj L.; Dadras O.; Ghadimi F.; Moradmand B.; Seyed A.S.; Epidemiology of HIV in Iran. Curr HIV Res 2020,18(4),228-236","journal-title":"Curr HIV Res"},{"year":"2020","author":"Hepatitis B.","key":"ref=5","unstructured":"Hepatitis B.;  Available from: 2020"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1871526516666151230115809","volume":"16","author":"Firouzeh M.M.","year":"2016","unstructured":"Firouzeh M.M.; Moradbeigi M.; Seyed A.S.A.; Demographic, clinical and laboratory profiles of HIV infected patients admitted into imam khomeini hospital of Tehran, Iran. Infect Disord Drug Targets 2016,16(2),113-120","journal-title":"Infect Disord Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"Razavi-Shearer D.","year":"2018","unstructured":"Razavi-Shearer D.; Gamkrelidze I.; Nguyen M.H.; Chen D-S.; Van Damme P.; Abbas Z.; Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study. Lancet Gastroenterol Hepatol 2018,3(6),383-403","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=8","first-page":"58","volume":"48","author":"Seyed A.S.A.","year":"2010","unstructured":"Seyed A.S.A.; Kheirandish P.; Karami N.; High prevalence of chronic hepatitis B infection among injection drug users in Iran: The need to increase vaccination of adults at risk. Acta Med Iran 2010,48(1),58-60","journal-title":"Acta Med Iran"},{"key":"ref=9","first-page":"252","volume":"49","author":"Seyed A.S.","year":"2011","unstructured":"Seyed A.S.; Jam S.; Mehrkhani F.; Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Med Iran 2011,49(4),252-257","journal-title":"Acta Med Iran"},{"key":"ref=10","first-page":"318","volume":"13","author":"Hosseini M","year":"2010","unstructured":"Hosseini M; SeyedAlinaghi S; Kheirandish P; Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Arch Iran Med 2010,13(4),318-323","journal-title":"Arch Iran Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","volume":"64","author":"Sureau C.","year":"2016","unstructured":"Sureau C.; Negro F.; The hepatitis delta virus: Replication and pathogenesis. J Hepatol 2016,64(1),S102-S116","journal-title":"J Hepatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e8351","DOI":"10.5812\/hepatmon.8351","volume":"13","author":"Sarvari J.","year":"2013","unstructured":"Sarvari J.; Mojtahedi Z.; Taghavi S.A.R.; Differentially expressed proteins in chronic active hepatitis, cirrhosis, and HCC related to HCV infection in comparison with HBV infection: A proteomics study. Hepat Mon 2013,13(7),e8351","journal-title":"Hepat Mon"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jvh.12043","volume":"20","author":"Kew M.C.","year":"2013","unstructured":"Kew M.C.; Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: An update. J Viral Hepat 2013,20(3),149-157","journal-title":"J Viral Hepat"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/vim.2016.0144","volume":"30","author":"Mansha S.","year":"2017","unstructured":"Mansha S.; Imran M.; Shah A.; Hepatitis B and C virus infections among human immunodeficiency virus-infected people who inject drugs in Lahore, Pakistan. Viral Immunol 2017,30(5),366-370","journal-title":"Viral Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.drugpo.2011.09.002","volume":"23","author":"Rahimi-Movaghar A.","year":"2012","unstructured":"Rahimi-Movaghar A.; Amin-Esmaeili M.; Haghdoost A.A.; Sadeghirad B.; Mohraz M.; HIV prevalence amongst injecting drug users in Iran: A systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy 2012,23(4),271-278","journal-title":"Int J Drug Policy"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12954-017-0172-z","volume":"14","author":"Buchanan R.","year":"2017","unstructured":"Buchanan R.; Khakoo S.I.; Coad J.; Grellier L.; Parkes J.; Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling. Harm Reduct J 2017,14(1),44","journal-title":"Harm Reduct J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e0151946","DOI":"10.1371\/journal.pone.0151946","volume":"11","author":"Bagheri Amiri F.","year":"2016","unstructured":"Bagheri Amiri F.; Mostafavi E.; Mirzazadeh A.; HIV, HBV and HCV co-infection prevalence in Iran-a systematic review and meta-analysis. PLoS One 2016,11(3),e0151946","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jmv.21078","volume":"80","author":"Cross T.J.","year":"2008","unstructured":"Cross T.J.; Rizzi P.; Horner M.; The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008,80(2),277-282","journal-title":"J Med Virol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1086\/341418","volume":"35","author":"Spaulding A.","year":"2002","unstructured":"Spaulding A.; Stephenson B.; Macalino G.; Ruby W.; Clarke J.G.; Flanigan T.P.; Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002,35(3),305-312","journal-title":"Clin Infect Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12876-020-01504-8","volume":"20","author":"Okafor I.M.","year":"2020","unstructured":"Okafor I.M.; Ugwu S.O.; Okoroiwu H.U.; Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison. BMC Gastroenterol 2020,20(1),360","journal-title":"BMC Gastroenterol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/jinf.2000.0647","volume":"40","author":"Taylor A.","year":"2000","unstructured":"Taylor A.; Goldberg D.; Hutchinson S.; Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect 2000,40(2),176-183","journal-title":"J Infect"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/ije\/26.6.1359","volume":"26","author":"Stark K.","year":"1997","unstructured":"Stark K.; Bienzle U.; Vonk R.; Guggenmoos-Holzmann I.; History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997,26(6),1359-1366","journal-title":"Int J Epidemiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/S0950268898001022","volume":"121","author":"Hutchinson S.J.","year":"1998","unstructured":"Hutchinson S.J.; Goldberg D.J.; Gore S.M.; Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiol Infect 1998,121(1),185-191","journal-title":"Epidemiol Infect"},{"key":"ref=24","first-page":"6","volume":"2","author":"Vieira D.","year":"2018","unstructured":"Vieira D.; Oliveira S.; Santos A.; Prevalence of viral hepatitis B, C and Delta, syphilis and HIV in the prison population in the closed penal system of the western Amazon. J Bacteriol Infect Dis 2018,2(2),6-11","journal-title":"J Bacteriol Infect Dis"},{"key":"ref=25","first-page":"622","volume":"9","author":"Tucker R.M.","year":"1987","unstructured":"Tucker R.M.; Gaffey M.J.; Fisch M.J.; Kaiser D.L.; Guerrant R.L.; Normansell D.E.; Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia State prisoners. Clin Ther 1987,9(6),622-628","journal-title":"Clin Ther"},{"key":"ref=26","first-page":"448","volume":"40","author":"Motamedifar M.","year":"2015","unstructured":"Motamedifar M.; Taheri M.; Lankarani K.B.; The prevalence and risk factors of hepatitis delta virus in HIV\/HBV co-infected patients in Shiraz, Iran, 2012. Iran J Med Sci 2015,40(5),448-453","journal-title":"Iran J Med Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1743-422X-8-102","volume":"8","author":"Ali M.","year":"2011","unstructured":"Ali M.; Idrees M.; Ali L.; Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J 2011,8(1),102","journal-title":"Virol J"},{"key":"ref=28","first-page":"107","volume":"19","author":"Chimphambano C.","year":"2007","unstructured":"Chimphambano C.; Komolafe I.; Muula A.; Prevalence of HIV, HepBsAg and Hep C antibodies among inmates in Chichiri prison, Blantyre, Malawi. Malawi Med J 2007,19(3),107-110","journal-title":"Malawi Med J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1186\/s12889-019-8011-7","volume":"19","author":"Wali A.","year":"2019","unstructured":"Wali A.; Khan D.; Safdar N.; Prevalence of tuberculosis, HIV\/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey. BMC Public Health 2019,19(1),1631","journal-title":"BMC Public Health"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12879-016-1601-4","volume":"16","author":"Jaquet A.","year":"2016","unstructured":"Jaquet A.; Wandeler G.; Tine J.; HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa. BMC Infect Dis 2016,16(1),249","journal-title":"BMC Infect Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12879-019-4581-3","volume":"19","author":"Gahrton C.","year":"2019","unstructured":"Gahrton C.; Westman G.; Lindahl K.; Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County. BMC Infect Dis 2019,19(1),955","journal-title":"BMC Infect Dis"},{"key":"ref=32","first-page":"164","volume":"94","author":"Bayas J.M.","year":"1990","unstructured":"Bayas J.M.; Bruguera M.; Mart\u00edn V.; Hepatitis B and hepatitis delta in young inmates. Med Clin 1990,94(5),164-168","journal-title":"Med Clin"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11908-012-0307-z","volume":"15","author":"Heidrich B.","year":"2013","unstructured":"Heidrich B.; Manns M.P.; Wedemeyer H.; Treatment options for hepatitis delta virus infection. Curr Infect Dis Rep 2013,15(1),31-38","journal-title":"Curr Infect Dis Rep"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","year":"2017","unstructured":"Liver eaftsot. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017,67(2),370-398","journal-title":"J Hepatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.7326\/M16-2575","volume":"166","author":"Falade-Nwulia O.","year":"2017","unstructured":"Falade-Nwulia O.; Suarez-Cuervo C.; Nelson D.R.; Fried M.W.; Segal J.B.; Sulkowski M.S.; Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann Intern Med 2017,166(9),637-648","journal-title":"Ann Intern Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jvh.12580","volume":"23","author":"Aspinall E.J.","year":"2016","unstructured":"Aspinall E.J.; Mitchell W.; Schofield J.; A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy. J Viral Hepat 2016,23(12),1009-1016","journal-title":"J Viral Hepat"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1590\/0037-868216972013","volume":"46","author":"Barros L.A.","year":"2013","unstructured":"Barros L.A.; Pessoni G.C.; Teles S.A.; Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goi\u00e1s, Central Brazil. Rev Soc Bras Med Trop 2013,46(1),24-29","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1089\/aid.2016.0271","volume":"33","author":"Belaunzaran-Zamudio P.F.","year":"2017","unstructured":"Belaunzaran-Zamudio P.F.; Mosqueda-Gomez J.L.; Macias-Hernandez A.; Rodr\u00edguez-Ram\u00edrez S.; Sierra-Madero J.; Beyrer C.; Burden of HIV, Syphilis, and hepatitis B and C among inmates in a prison state system in Mexico. AIDS Res Hum Retroviruses 2017,33(6),524-533","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e0179931","DOI":"10.1371\/journal.pone.0179931","volume":"12","author":"Belaunzar\u00e1n-Zamudio P.F.","year":"2017","unstructured":"Belaunzar\u00e1n-Zamudio P.F.; Mosqueda-Gomez J.L.; Macias-Hernandez A.; Sierra-Madero J.G.; Ahmed S.; Beyrer C.; Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. PLoS One 2017,12(6),e0179931","journal-title":"PLoS One"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5694\/j.1326-5377.2010.tb03605.x","volume":"192","author":"Boonwaat L.","year":"2010","unstructured":"Boonwaat L.; Haber P.S.; Levy M.H.; Lloyd A.R.; Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Med J Aust 2010,192(9),496-500","journal-title":"Med J Aust"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jvh.12701","volume":"24","author":"Cunningham E.B.","year":"2017","unstructured":"Cunningham E.B.; Hajarizadeh B.; Bretana N.A.; Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study. J Viral Hepat 2017,24(9),733-741","journal-title":"J Viral Hepat"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0956462414531242","volume":"26","author":"El Maerrawi I.","year":"2015","unstructured":"El Maerrawi I.; Carvalho H.B.; Prevalence and risk factors associated with HIV infection, hepatitis and syphilis in a state prison of S\u00e3o Paulo. Int J STD AIDS 2015,26(2),120-127","journal-title":"Int J STD AIDS"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1108\/IJPH-10-2015-0033","volume":"12","author":"Getaz L.","year":"2016","unstructured":"Getaz L.; Casillas A.; Motamed S.; Gaspoz J.M.; Chappuis F.; Wolff H.; Hepatitis A immunity and region-of-origin in a Swiss prison. Int J Prison Health 2016,12(2),98-105","journal-title":"Int J Prison Health"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"020407","DOI":"10.7189\/jogh.08.020407","volume":"8","author":"G\u00e9taz L.","year":"2018","unstructured":"G\u00e9taz L.; Casillas A.; Siegrist C.A.; Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland\u2019s largest pre-trial prison. J Glob Health 2018,8(2),020407","journal-title":"J Glob Health"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12954-020-00431-x","volume":"17","author":"Hariri S.","year":"2020","unstructured":"Hariri S.; Sharafi H.; Sheikh M.; Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era. Harm Reduct J 2020,17(1),80","journal-title":"Harm Reduct J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e0218482","DOI":"10.1371\/journal.pone.0218482","volume":"14","author":"Izquierdo L.","year":"2019","unstructured":"Izquierdo L.; Mellon G.; Buchaillet C.; Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates. PLoS One 2019,14(6),e0218482","journal-title":"PLoS One"},{"key":"ref=47","first-page":"S156","volume":"3","author":"Kassaian N.","year":"2012","unstructured":"Kassaian N.; Adibi P.; Kafashaian A.; Hepatitis C Virus and associated risk factors among prison inmates with history of drug injection in Isfahan, Iran. Int J Prev Med 2012,3,S156-S161","journal-title":"Int J Prev Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"E674","DOI":"10.9778\/cmajo.20190068","volume":"7","author":"Kronfli N.","year":"2019","unstructured":"Kronfli N.; Dussault C.; Klein M.B.; Lebouch\u00e9 B.; Sebastiani G.; Cox J.; The hepatitis C virus cascade of care in a Quebec provincial prison: a retrospective cohort study. CMAJ Open 2019,7(4),E674-E679","journal-title":"CMAJ Open"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1016\/j.vaccine.2020.02.076","volume":"38","author":"Li H.","year":"2020","unstructured":"Li H.; Cameron B.; Douglas D.; Incident Hepatitis B virus infection and immunisation uptake in Australian prison inmates. Vaccine 2020,38(16),3255-3260","journal-title":"Vaccine"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1365-3156.2010.02655.x","volume":"15","author":"Nelwan E.J.","year":"2010","unstructured":"Nelwan E.J.; Van Crevel R.; Alisjahbana B.; Human immunodeficiency virus, Hepatitis B and Hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Trop Med Int Health 2010,15(12),1491-1498","journal-title":"Trop Med Int Health"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4038\/cmj.v60i1.7288","volume":"60","author":"Niriella M.A.","year":"2015","unstructured":"Niriella M.A.; Hapangama A.; Luke H.P.; Pathmeswaran A.; Kuruppuarachchi K.A.; de Silva H.J.; Prevalence of Hepatitis B and Hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates. Ceylon Med J 2015,60(1),18-20","journal-title":"Ceylon Med J"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1590\/S0037-86822010000500008","volume":"43","author":"Stief A.C.","year":"2010","unstructured":"Stief A.C.; Martins R.M.; Andrade S.M.; Seroprevalence of Hepatitis B virus infection and associated factors among prison inmates in state of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop 2010,43(5),512-515","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12954-015-0045-2","volume":"12","author":"Treloar C.","year":"2015","unstructured":"Treloar C.; McCredie L.; Lloyd A.R.; Acquiring hepatitis C in prison: the social organisation of injecting risk. Harm Reduct J 2015,12,10","journal-title":"Harm Reduct J"},{"key":"ref=54","first-page":"47","volume":"20","author":"Villarroel-Torrico M.","year":"2018","unstructured":"Villarroel-Torrico M.; Monta\u00f1o K.; Flores-Arispe P.; Syphilis, human immunodeficiency virus, herpes genital and Hepatitis B in a women\u2019s prison in Cochabamba, Bolivia: prevalence and risk factors. Rev Esp Sanid Penit 2018,20(2),47-54","journal-title":"Rev Esp Sanid Penit"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/pubmed\/fdq083","volume":"33","author":"Viswanathan U.","year":"2011","unstructured":"Viswanathan U.; Beaumont A.; O\u2019Moore E.; Hepatitis B transmission event in an English prison and the importance of immunization. J Public Health (Oxf) 2011,33(2),193-196","journal-title":"J Public Health (Oxf)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1099\/jmm.0.46414-0","volume":"55","author":"Adjei A.A.","year":"2006","unstructured":"Adjei A.A.; Armah H.B.; Gbagbo F.; Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol 2006,55(Pt 5),593-597","journal-title":"J Med Microbiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.3748\/wjg.v11.i26.4085","volume":"11","author":"Mohammad A.H.","year":"2005","unstructured":"Mohammad A.H.; Alavian S.M.; Jafari K.; Yazdi N.; Prevalence of Hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol 2005,11(26),4085-4089","journal-title":"World J Gastroenterol"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dld.2010.12.004","volume":"43","author":"Almasio P.L.","year":"2011","unstructured":"Almasio P.L.; Babudieri S.; Barbarini G.; Brunetto M.; Conte D.; Dentico P.; Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Digest Liver Dis 2011,43(8),589-595","journal-title":"Digest Liver Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5694\/mja13.11062","volume":"200","author":"Reekie J.M.","year":"2014","unstructured":"Reekie J.M.; Levy M.H.; Richards A.H.; Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010. Med J Aust 2014,200(5),277-280","journal-title":"Med J Aust"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3855\/jidc.2965","volume":"7","author":"Prasetyo A.A.","year":"2013","unstructured":"Prasetyo A.A.; Dirgahayu P.; Sari Y.; Hudiyono H.; Kageyama S.; Molecular epidemiology of HIV, HBV, HCV, and HTLV-1\/2 in drug abuser inmates in central Javan prisons, Indonesia. J Infect Dev Ctries 2013,7(6),453-467","journal-title":"J Infect Dev Ctries"},{"key":"ref=61","first-page":"162","volume":"10","author":"Alavian S","year":"2009","unstructured":"Alavian S; Fallahian F.;  Epidemiology of Hepatitis C in Iran and the World 2009,10(4),162-172","journal-title":"Epidemiology of Hepatitis C in Iran and the World"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e0169195","DOI":"10.1371\/journal.pone.0169195","volume":"12","author":"Puga M.A.","year":"2017","unstructured":"Puga M.A.; Bandeira L.M.; Pompilio M.A.; Prevalence and incidence of HCV Infection among Prisoners in Central Brazil. PLoS One 2017,12(1),e0169195","journal-title":"PLoS One"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"62S","DOI":"10.1002\/hep.510260711","volume":"26","author":"Alter M.J.","year":"1997","unstructured":"Alter M.J.; Epidemiology of hepatitis C. Hepatology 1997,26(3),62S-65S","journal-title":"Hepatology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1386-6532(02)00116-6","volume":"26","author":"Dore G.J.","year":"2003","unstructured":"Dore G.J.; Law M.; MacDonald M.; Kaldor J.M.; Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003,26(2),171-184","journal-title":"J Clin Virol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S1473-3099(06)70685-5","volume":"7","author":"Dolan K.","year":"2007","unstructured":"Dolan K.; Kite B.; Black E.; Aceijas C.; Stimson G.V.; HIV in prison in low-income and middle-income countries. Lancet Infect Dis 2007,7(1),32-41","journal-title":"Lancet Infect Dis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2334-3-25","volume":"3","author":"Thaisri H.","year":"2003","unstructured":"Thaisri H.; Lerwitworapong J.; Vongsheree S.; HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infect Dis 2003,3,25","journal-title":"BMC Infect Dis"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/S0102-311X2007000100021","volume":"23","author":"Strazza L.","year":"2007","unstructured":"Strazza L.; Massad E.; Azevedo R.S.; Carvalho H.B.; Behavior associated with HIV and HCV infection in female prison inmates in S\u00e3o Paulo, Brazil. Cad Saude Publica 2007,23(1),197-205","journal-title":"Cad Saude Publica"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/j.1360-0443.2006.01617.x","volume":"101","author":"Sarang A.","year":"2006","unstructured":"Sarang A.; Rhodes T.; Platt L.; Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: Qualitative study. Addiction 2006,101(12),1787-1796","journal-title":"Addiction"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/bmj.310.6975.289","volume":"310","author":"Taylor A.","year":"1995","unstructured":"Taylor A.; Goldberg D.; Emslie J.; Outbreak of HIV infection in a Scottish prison. BMJ 1995,310(6975),289-292","journal-title":"BMJ"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAI.0b013e3181be6dde","volume":"53","author":"Kheirandish P.","year":"2010","unstructured":"Kheirandish P.; Seyedalinaghi S.A.; Hosseini M.; Jahani M.R.; Shirzad H.; Foroughi M.; Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran. J Acquir Immune Defic Syndromes 2010,53(2),273-275","journal-title":"J Acquir Immune Defic Syndromes"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1097\/01.aids.0000343764.62455.9e","volume":"22","author":"Mahanta J.","year":"2008","unstructured":"Mahanta J.; Medhi G.K.; Paranjape R.S.; Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS 2008,22,S59-S68","journal-title":"AIDS"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/02791072.2004.10400032","volume":"36","author":"Maranda M.J.","year":"2004","unstructured":"Maranda M.J.; Han C.; Rainone G.A.; Crack cocaine and sex. J Psychoactive Drugs 2004,36(3),315-322","journal-title":"J Psychoactive Drugs"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1017\/S0950268805003961","volume":"133","author":"Alvarado-Esquivel C.","year":"2005","unstructured":"Alvarado-Esquivel C.; Sablon E.; Mart\u00ednez-Garc\u00eda S.; Estrada-Mart\u00ednez S.; Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico. Epidemiol Infect 2005,133(4),679-685","journal-title":"Epidemiol Infect"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ajic.2006.08.002","volume":"35","author":"Hellard M.E.","year":"2007","unstructured":"Hellard M.E.; Aitken C.K.; Hocking J.S.; Tattooing in prisons--not such a pretty picture. Am J Infect Control 2007,35(7),477-480","journal-title":"Am J Infect Control"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1017\/S0950268801006197","volume":"127","author":"Samuel M.C.","year":"2001","unstructured":"Samuel M.C.; Doherty P.M.; Bulterys M.; Jenison S.A.; Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect 2001,127(3),475-484","journal-title":"Epidemiol Infect"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/bmj.321.7265.899","volume":"321","author":"Crofts N.","year":"2000","unstructured":"Crofts N.; Caruana S.; Bowden S.; Kerger M.; Minimising harm from hepatitis C virus needs better strategies. BMJ 2000,321(7265),899","journal-title":"BMJ"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/pubmed\/fdu022","volume":"37","author":"Humphreys C.","year":"2015","unstructured":"Humphreys C.; Railton C.; O\u2019Moore \u00c9.; Lombard M.; Newton A.; An audit of hepatitis C service provision in a representative sample of prisons in England. J Public Health 2015,37(1),151-156","journal-title":"J Public Health"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12879-019-4344-1","volume":"19","author":"Akiyama M.J.","year":"2019","unstructured":"Akiyama M.J.; Columbus D.; MacDonald R.; Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial. BMC Infect Dis 2019,19(1),703","journal-title":"BMC Infect Dis"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/pubmed\/fdv023","volume":"38","author":"Beckwith C.G.","year":"2016","unstructured":"Beckwith C.G.; Kurth A.E.; Bazerman L.B.; A pilot study of rapid hepatitis C virus testing in the Rhode island department of corrections. J Public Health 2016,38(1),130-137","journal-title":"J Public Health"},{"key":"ref=80","first-page":"98","volume":"2","author":"Schoenbachler BT","year":"2016","unstructured":"Schoenbachler BT; Smith BD; Se\u00f1a AC; Hilton A; Bachman S; Lunda M; Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014. Public health reports (Washington, DC: 1974) 2016,2(2),98-104"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40352-018-0063-8","volume":"6","author":"Kendall S.","year":"2018","unstructured":"Kendall S.; Redshaw S.; Ward S.; Wayland S.; Sullivan E.; Systematic review of qualitative evaluations of reentry programs addressing problematic drug use and mental health disorders amongst people transitioning from prison to communities. Health Justice 2018,6(1),4","journal-title":"Health Justice"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1708-8305.2008.00230.x","volume":"15","author":"Majori S.","year":"2008","unstructured":"Majori S.; Baldo V.; Tommasi I.; Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy). J Travel Med 2008,15(5),323-327","journal-title":"J Travel Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"Schweitzer A.","year":"2015","unstructured":"Schweitzer A.; Horn J.; Mikolajczyk R.T.; Krause G.; Ott J.J.; Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015,386(10003),1546-1555","journal-title":"Lancet"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1743-422X-8-96","volume":"8","author":"Durro V.","year":"2011","unstructured":"Durro V.; Qyra S.; Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J 2011,8,96","journal-title":"Virol J"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.7156\/V411P007","volume":"4","author":"Hwang EW","year":"2011","unstructured":"Hwang EW; Global epidemiology of hepatitis B virus (HBV) infection. 2011,4(1)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.patbio.2011.06.001","volume":"60","author":"Sbai A.","year":"2012","unstructured":"Sbai A.; Baha W.; Ougabrai H.; Hepatitis B prevalence and risk factors in Morocco. Pathol Biol 2012,60(5),e65-e69","journal-title":"Pathol Biol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/(SICI)1096-9071(199603)48:3<262::AID-JMV8>3.0.CO;2-6","volume":"48","author":"Corona R.","year":"1996","unstructured":"Corona R.; Caprilli F.; Giglio A.; Risk factors for hepatitis B virus infection among heterosexuals attending a sexually transmitted diseases clinic in Italy: role of genital ulcerative diseases. J Med Virol 1996,48(3),262-266","journal-title":"J Med Virol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jmv.21464","volume":"81","author":"Ferreira R.C.","year":"2009","unstructured":"Ferreira R.C.; Rodrigues F.P.; Teles S.A.; Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users. J Med Virol 2009,81(4),602-609","journal-title":"J Med Virol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jmv.21046","volume":"80","author":"Nascimento M.C.","year":"2008","unstructured":"Nascimento M.C.; Mayaud P.; Sabino E.C.; Torres K.L.; Franceschi S.; Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol 2008,80(1),53-57","journal-title":"J Med Virol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jmv.20375","volume":"76","author":"Babudieri S.","year":"2005","unstructured":"Babudieri S.; Longo B.; Sarmati L.; Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol 2005,76(3),311-317","journal-title":"J Med Virol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1753-6405.2007.00009.x","volume":"31","author":"Butler T.","year":"2007","unstructured":"Butler T.; Boonwaat L.; Hailstone S.; The 2004 Australian prison entrants\u2019 blood-borne virus and risk behaviour survey. Aust N Z J Public Health 2007,31(1),44-50","journal-title":"Aust N Z J Public Health"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2334-8-33","volume":"8","author":"Adjei A.A.","year":"2008","unstructured":"Adjei A.A.; Armah H.B.; Gbagbo F.; Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infect Dis 2008,8,33","journal-title":"BMC Infect Dis"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3855\/jidc.472","volume":"3","author":"Adoga M.P.","year":"2009","unstructured":"Adoga M.P.; Banwat E.B.; Forbi J.C.; Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries 2009,3(7),539-547","journal-title":"J Infect Dev Ctries"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"w13793","DOI":"10.4414\/smw.2013.13793","volume":"143","author":"Fretz R.","year":"2013","unstructured":"Fretz R.; Negro F.; Bruggmann P.; Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss Med Wkly 2013,143,w13793","journal-title":"Swiss Med Wkly"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"460","DOI":"10.7326\/0003-4819-147-7-200710020-00004","volume":"147","author":"Hutton D.W.","year":"2007","unstructured":"Hutton D.W.; Tan D.; So S.K.; Brandeau M.L.; Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med 2007,147(7),460-469","journal-title":"Ann Intern Med"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1365-2893.1997.00059.x","volume":"4","author":"Crofts N.","year":"1997","unstructured":"Crofts N.; Cooper G.; Stewart T.; Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria. J Viral Hepat 1997,4(5),333-338","journal-title":"J Viral Hepat"},{"key":"ref=97","first-page":"133","volume":"4","author":"Skidmore S.","year":"2001","unstructured":"Skidmore S.; Parry J.V.; Nottage P.; An investigation of the potential risk of an HAV outbreak in a prison population following the introduction of cases from a community outbreak. Commun Dis Public Health 2001,4(2),133-135","journal-title":"Commun Dis Public Health"},{"key":"ref=98","first-page":"277","volume":"5","author":"Whiteman D","year":"1998","unstructured":"Whiteman D; McCall B; Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control. 1998,5(4),277-83"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF01644310","volume":"16","author":"Holter E.","year":"1988","unstructured":"Holter E.; Siebke J.C.; Hepatitis A in young Norwegian drug addicts and prison inmates. Infection 1988,16(2),91-94","journal-title":"Infection"},{"key":"ref=100","first-page":"1","volume":"52","author":"Weinbaum C","year":"2003","unstructured":"Weinbaum C; Lyerla R; Margolis HS; Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports 2003,52(1),1-36","journal-title":"Centers for Disease Control and Prevention MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"84S","DOI":"10.1016\/j.amjmed.2005.07.025","volume":"118","author":"Gondles E.F.","year":"2005","unstructured":"Gondles E.F.; A call to immunize the correctional population for hepatitis A and B. Am J Med 2005,118(10),84S-89S","journal-title":"Am J Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2893.2004.00503.x","volume":"11","author":"Roy K.","year":"2004","unstructured":"Roy K.; Howie H.; Sweeney C.; Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: a case-control study. J Viral Hepat 2004,11(3),277-282","journal-title":"J Viral Hepat"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3109\/00365548.2010.511259","volume":"42","author":"G\u00e9taz L.","year":"2010","unstructured":"G\u00e9taz L.; Siegrist C.A.; Stoll B.; Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures. Scand J Infect Dis 2010,42(11-12),936-940","journal-title":"Scand J Infect Dis"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2893.2009.01257.x","volume":"17","author":"Meng X.J.","year":"2010","unstructured":"Meng X.J.; Recent advances in Hepatitis E virus. J Viral Hepat 2010,17(3),153-161","journal-title":"J Viral Hepat"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s15010-006-4132-x","volume":"34","author":"Preiss J.C.","year":"2006","unstructured":"Preiss J.C.; Plentz A.; Engelmann E.; Autochthonous Hepatitis E virus infection in Germany with sequence similarities to other European isolates. Infection 2006,34(3),173-175","journal-title":"Infection"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s15010-011-0220-7","volume":"40","author":"Pfefferle S.","year":"2012","unstructured":"Pfefferle S.; Frickmann H.; Gabriel M.; Schmitz N.; G\u00fcnther S.; Schmidt-Chanasit J.; Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany. Infection 2012,40(4),451-454","journal-title":"Infection"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcv.2009.10.011","volume":"47","author":"Brost S.","year":"2010","unstructured":"Brost S.; Wenzel J.J.; Ganten T.M.; Filser M.; Flechtenmacher C.; Boehm S.; Sporadic cases of acute autochthonous Hepatitis E virus infection in Southwest Germany. J Clin Virol 2010,47(1),89-92","journal-title":"J Clin Virol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jhep.2007.12.008","volume":"48","author":"Purcell R.H.","year":"2008","unstructured":"Purcell R.H.; Emerson S.U.; Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008,48(3),494-503","journal-title":"J Hepatol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/j.1537-2995.2008.01722.x","volume":"48","author":"Matsubayashi K.","year":"2008","unstructured":"Matsubayashi K.; Kang J.H.; Sakata H.; A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008,48(7),1368-1375","journal-title":"Transfusion"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jhep.2010.06.017","volume":"54","author":"Roman\u00f2 L.","year":"2011","unstructured":"Roman\u00f2 L.; Paladini S.; Tagliacarne C.; Canuti M.; Bianchi S.; Zanetti A.R.; Hepatitis E in Italy: a long-term prospective study. J Hepatol 2011,54(1),34-40","journal-title":"J Hepatol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/jmv.1890420321","volume":"42","author":"Zanetti A.R.","year":"1994","unstructured":"Zanetti A.R.; Dawson G.J.; Hepatitis type E in Italy: a seroepidemiological survey. J Med Virol 1994,42(3),318-320","journal-title":"J Med Virol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2893.1996.tb00095.x","volume":"3","author":"Gessoni G.","year":"1996","unstructured":"Gessoni G.; Manoni F.; Hepatitis E virus infection in north-east Italy: serological study in the open population and groups at risk. J Viral Hepat 1996,3(4),197-202","journal-title":"J Viral Hepat"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/(SICI)1096-9071(199905)58:1<49:AID-JMV7>3.0.CO;2-C","volume":"58","author":"Rapicetta M.","year":"1999","unstructured":"Rapicetta M.; Kondili L.A.; Pretolani S.; Seroprevalence and anti-HEV persistence in the general population of the Republic of San Marino. J Med Virol 1999,58(1),49-53","journal-title":"J Med Virol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/hep.28436","volume":"63","author":"Mansuy J.M.","year":"2016","unstructured":"Mansuy J.M.; Gallian P.; Dimeglio C.; A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology 2016,63(4),1145-1154","journal-title":"Hepatology"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s15010-012-0385-8","volume":"41","author":"Rapicetta M.","year":"2013","unstructured":"Rapicetta M.; Monarca R.; Kondili L.A.; Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. Infection 2013,41(1),69-76","journal-title":"Infection"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s11524-009-9393-0","volume":"86","author":"Kheirandish P","year":"2009","unstructured":"Kheirandish P; SeyedAlinaghi S; Jahani M; Shirzad H; Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. J Urban Health 2009,86(6),902-908","journal-title":"J Urban Health"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S2222-1808(15)60989-6","volume":"6","author":"Farhoudi B.","year":"2016","unstructured":"Farhoudi B.; SeyedAlinaghi SA, Mohraz M, Hosseini M, Farnia M. Tuberculosis, hepatitis C and hepatitis B co-infections in patients with HIV in the Great Tehran Prison, Iran. Asian Pac J Trop Dis 2016,6(1),82-83","journal-title":"Asian Pac J Trop Dis"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1108\/JHR-04-2019-0068","volume":"34","author":"Farhoudi B","year":"2020","unstructured":"Farhoudi B; SeyedAlinaghi S; Dadras O; Health service provision for disease control among prisoners: a conceptual note. J Health Res 2020,34(4),353-358","journal-title":"J Health Res"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220620115006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206190\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220620115006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:17:31Z","timestamp":1693160251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206190\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526522666220620115006","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e200622206190"}}